Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by RMR Wealth Builders

RMR Wealth Builders increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.3% in the 4th quarter, HoldingsChannel reports. The firm owned 5,699 shares of the medical equipment provider’s stock after buying an additional 236 shares during the quarter. RMR Wealth Builders’ holdings in Intuitive Surgical were worth $2,975,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Andra AP fonden acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth $178,000. MGO One Seven LLC raised its holdings in Intuitive Surgical by 76.2% in the second quarter. MGO One Seven LLC now owns 4,090 shares of the medical equipment provider’s stock valued at $1,819,000 after buying an additional 1,769 shares during the period. LPL Financial LLC lifted its position in Intuitive Surgical by 9.2% during the second quarter. LPL Financial LLC now owns 294,740 shares of the medical equipment provider’s stock valued at $131,115,000 after buying an additional 24,715 shares in the last quarter. Hazlett Burt & Watson Inc. raised its position in Intuitive Surgical by 98.8% in the second quarter. Hazlett Burt & Watson Inc. now owns 342 shares of the medical equipment provider’s stock valued at $154,000 after purchasing an additional 170 shares during the period. Finally, American Century Companies Inc. grew its position in Intuitive Surgical by 3.0% in the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock valued at $1,066,837,000 after acquiring an additional 70,556 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird boosted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Finally, Royal Bank of Canada lifted their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Trading Up 0.6 %

Intuitive Surgical stock traded up $3.45 during mid-day trading on Friday, hitting $547.47. 1,732,022 shares of the company’s stock were exchanged, compared to its average volume of 1,340,430. The stock has a 50 day moving average of $535.11 and a two-hundred day moving average of $493.61. Intuitive Surgical, Inc. has a 1-year low of $355.17 and a 1-year high of $556.23. The stock has a market cap of $195.00 billion, a P/E ratio of 88.02, a P/E/G ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. As a group, research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock worth $25,012,927 in the last ninety days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.